eFHS Messaging Trial

Sponsor
Boston University (Other)
Overall Status
Completed
CT.gov ID
NCT03516019
Collaborator
Robert Wood Johnson Foundation (Other)
650
1
8
10.1
64.2

Study Details

Study Description

Brief Summary

In this research the investigators will develop and test an innovative scalable mobile health and digital cardiovascular monitoring system within a longitudinal deeply characterized cohort with three components: 1) smartphone application (app) designed to promote adherence, integrate digital and mHealth information, and facilitate communication with participants and researchers; 2) smartwatch activity monitoring using the Apple iWatch; and 3) home blood pressure (BP) monitoring using the Withings blood pressure device.

The objective of the messaging trial is to test the effect of messaging strategies on improving participants' long-term use of and engagement with our selected mobile health technologies and on increasing response rate of survey data collection.

Condition or Disease Intervention/Treatment Phase
  • Other: personalized notices
  • Other: standard notices
  • Other: am notices
  • Other: pm notices
  • Other: weekday notices
  • Other: weekend notices
N/A

Detailed Description

The research design includes a cohort eFHS Study and an embedded randomized factorial trial on a subset of the cohort.

For the primary e-cohort, the investigators will build a custom mobile app for use within the Framingham Heart Study (FHS) to digitally collect data, compare it against research clinic-collected data, quantify risk factor burden, and perform CVD risk prediction. The app development will focus on 1) CVD risk factor data that would benefit from more frequent ascertainment than the every four to eight year FHS examination cycles; 2) circumstances where in vivo assessment may be superior to clinic-based assessment; 3) key endpoints of the FHS that are considered FHS landmarks. In addition to the eFHS App, participants will be offered wireless devices (Withings BP) to measure blood pressure and an Apple Watch to measure heart rate and steps per day.

For the messaging trial, the investigators will conduct a randomized factorial trial phase to test the effect of messaging strategies. Participants will be sent a weekly notification through the eFHS app. Participants will be randomly allocated to one of 8 groups defined according to the following: using personalized reminder messaging vs. standard neutral messaging; notification sent on a weekday vs. weekend; notification sent in the morning vs. the evening. The three main comparisons will be simultaneously evaluated according to a 2x2x2 factorial design.

Study Design

Study Type:
Interventional
Actual Enrollment :
650 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Intervention Model Description:
The research design includes a cohort eFHS Study and an embedded randomized factorial trial on a subset of the cohort.The research design includes a cohort eFHS Study and an embedded randomized factorial trial on a subset of the cohort.
Masking:
Single (Investigator)
Masking Description:
eFHS researchers, statistician, research assistant, and clinic staff are masked to intervention assignment.
Primary Purpose:
Prevention
Official Title:
Messaging Intervention Trial in the Electronic Framingham Heart Study (eFHS)
Actual Study Start Date :
May 19, 2018
Actual Primary Completion Date :
Mar 23, 2019
Actual Study Completion Date :
Mar 23, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Weekday am personalized notices

Participants in this arm receive personalized weekday am notices on Wednesday at 7am.

Other: personalized notices
The personalized notices take into account if data were received over the previous week, and accordingly encourages the participant to use the device and send her data, or encourages the participant to continue using the device and sending data. A library of personalized notices with alternative motivational content was developed. Each time a notification is sent, it will be drawn at random from the library.

Other: am notices
notifications sent at 7 am.

Other: weekday notices
notifications sent on Wednesday

Experimental: Weekday pm personalized notices

Participants in this arm receive a personalized weekday pm notices on Wednesday at 7pm.

Other: personalized notices
The personalized notices take into account if data were received over the previous week, and accordingly encourages the participant to use the device and send her data, or encourages the participant to continue using the device and sending data. A library of personalized notices with alternative motivational content was developed. Each time a notification is sent, it will be drawn at random from the library.

Other: pm notices
notifications sent at 7 pm.

Other: weekday notices
notifications sent on Wednesday

Experimental: Weekend am personalized notices

Participants in this arm receive a personalized weekend am notices on Saturday at 7am.

Other: personalized notices
The personalized notices take into account if data were received over the previous week, and accordingly encourages the participant to use the device and send her data, or encourages the participant to continue using the device and sending data. A library of personalized notices with alternative motivational content was developed. Each time a notification is sent, it will be drawn at random from the library.

Other: am notices
notifications sent at 7 am.

Other: weekend notices
notifications sent on Saturday

Experimental: Weekend pm personalized notices

Participants in this arm receive personalized pm notices on Saturday at 7pm.

Other: personalized notices
The personalized notices take into account if data were received over the previous week, and accordingly encourages the participant to use the device and send her data, or encourages the participant to continue using the device and sending data. A library of personalized notices with alternative motivational content was developed. Each time a notification is sent, it will be drawn at random from the library.

Other: pm notices
notifications sent at 7 pm.

Other: weekend notices
notifications sent on Saturday

Experimental: Weekday am standard notices

Participants in this arm receive standard weekday notices on Wednesday at 7am.

Other: standard notices
The standard notices which are neutral and invite participants to wear the watch daily and to measure their blood pressure weekly.

Other: am notices
notifications sent at 7 am.

Other: weekday notices
notifications sent on Wednesday

Experimental: Weekday pm standard notices

Participants in this arm receive standard weekday notices on Wednesday at 7pm

Other: standard notices
The standard notices which are neutral and invite participants to wear the watch daily and to measure their blood pressure weekly.

Other: pm notices
notifications sent at 7 pm.

Other: weekday notices
notifications sent on Wednesday

Experimental: Weekend am standard notices

Participants in this arm receive standard weekend notices on Saturday at 7am

Other: standard notices
The standard notices which are neutral and invite participants to wear the watch daily and to measure their blood pressure weekly.

Other: am notices
notifications sent at 7 am.

Other: weekend notices
notifications sent on Saturday

Experimental: Weekend pm standard notices

Participants in this arm receive standard weekend notices on Saturday at 7pm

Other: standard notices
The standard notices which are neutral and invite participants to wear the watch daily and to measure their blood pressure weekly.

Other: pm notices
notifications sent at 7 pm.

Other: weekend notices
notifications sent on Saturday

Outcome Measures

Primary Outcome Measures

  1. Adherence at 3 months to the weekly BP recording [3 months]

    proportion of participants who submit their weekly blood pressure measurement at 3 months

  2. Adherence at 3 months to the weekly HR recording [3 months]

    proportion of participants who submit their weekly heart rate measurement at 3 months

Secondary Outcome Measures

  1. Adherence at one month to the weekly BP recording [1 month]

    proportion of participants who submit their weekly blood pressure measurement at 1 month

  2. Adherence at one month to the weekly HR recording [1 month]

    proportion of participants who submit their weekly heart rate measurement at 1 month

Other Outcome Measures

  1. Adherence to survey response [3 months]

    proportion of participants who complete the eFHS survey at 3 months

  2. Adherence at 6 months to the weekly BP recording [6 months]

    Comparison between the groups receiving personalized notices to the groups receiving standard notices

  3. Adherence at 6 months to the weekly HR recording [6 months]

    Comparison between the groups receiving personalized notices to the groups receiving standard notices

  4. Adherence at 6 months to survey response [6 months]

    Comparison between the groups receiving personalized notices to the groups receiving standard notices

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria for the eFHS study:
  • Participants of the FHS Third Generation, Omni Group 2, and New Offspring Spouse Cohorts attending the in-person examination 3 with access to a smartphone or home internet access and English speaking/reading.
Specifically for the RCT substudy (re: engagement with select mobile health technologies):
  • English-speaking individual

  • Owns an iPhone with compatible iOS (version 9 or higher);

  • Residence in the United States

  • Provision of permissions for notifications and data sharing with the Research Center

  • Provision of signed and dated informed consent

Exclusion Criteria:
  • Participants who do not meet the inclusion criteria

Contacts and Locations

Locations

Site City State Country Postal Code
1 Framingham Heart Study Boston Massachusetts United States 02118

Sponsors and Collaborators

  • Boston University
  • Robert Wood Johnson Foundation

Investigators

  • Principal Investigator: Joanne Murabito, MD ScM, Framingham Heart Study

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Boston University
ClinicalTrials.gov Identifier:
NCT03516019
Other Study ID Numbers:
  • H-36586
  • 74624
First Posted:
May 4, 2018
Last Update Posted:
Feb 11, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Boston University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 11, 2021